Welcome to our dedicated page for Quantum SEC filings (Ticker: QMCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Quantum Corporation (NASDAQ: QMCO) SEC filings page provides direct access to the company’s regulatory disclosures, offering detailed insight into its financial condition, capital structure, governance, and data management business. As a Delaware corporation listed on the Nasdaq Global Market, Quantum files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and registration statements such as Form S-1.
Through these filings, investors can review segment-level revenue details, cost structures, and non-GAAP reconciliations that Quantum discusses in its earnings releases. Forms 10-K and 10-Q typically include information on product, service and subscription, and royalty revenue, gross profit, operating expenses, cash flows, and risk factors related to its data management platform for unstructured data.
Quantum’s Form 8-K filings document material events such as the Transaction Agreement and subsequent closing of a debt exchange with Dialectic Technology SPV LLC, the issuance of senior secured convertible notes, changes to its term loan facility, the grant of a Forbearance Warrant, and the appointment of CohnReznick LLP as independent registered public accounting firm. Other 8-Ks cover preliminary and final quarterly financial results, Nasdaq compliance updates, and the establishment of annual meeting dates.
The company’s DEF 14A proxy statements describe board composition, director elections, executive compensation, equity incentive plans, and shareholder proposals, while the S-1 registration statement filed in November 2025 outlines the resale of common stock issuable under the Forbearance Warrant and provides additional background on Quantum’s unstructured data and AI-focused business.
On this page, Stock Titan surfaces Quantum’s latest SEC filings as they are made available on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight key points from lengthy documents—such as major financing terms, covenant changes, or governance proposals—so readers can more quickly understand the implications of 10-Ks, 10-Qs, 8-Ks, S-1s, and proxy materials. Users can also examine insider-related information through ownership and warrant disclosures contained in these filings.
Quantum Corporation filed a Form 12b-25 to notify that it will not meet the original due date for its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. The company says it cannot file by August 14, 2025 without unreasonable effort or expense because it needs additional time to finalize its financial statements and for its independent auditor to complete their review, including financial statements in the Annual Report on Form 10-K for the year ended March 31, 2025.
The company highlights uncertainties around its ongoing review procedures, including accounting related to revenue contracts and application of standalone selling price, and notes that these processes could uncover additional information or lead to changes in assumptions. It also cites risks related to legal proceedings and investigations, stock exchange continued listing standards, and its ability to maintain effective internal control over financial reporting.
Quantum Corporation concluded that its previously issued unaudited interim condensed consolidated financial statements for the fiscal third quarter ended December 31, 2024 are no longer reliable and will be restated. Management identified inconsistencies in service and subscription revenue accounted for under Topic 606 and updated the periods over which revenue is recognized and the standalone selling prices for the fiscal year ended March 31, 2025. The company currently expects the Restatement will decrease revenue and similarly decrease net loss from operations by approximately $3.9 million for the Non-Reliance Period. The Audit Committee determined there were material weaknesses in internal control over financial reporting and disclosure controls related to revenue recognition as of December 31, 2024 and March 31, 2025. Adjustments to other quarters were not material and will be revised in comparative period information. The Audit Committee discussed these matters with Grant Thornton LLP.